Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Nutr Metab Cardiovasc Dis ; 24(10): 1112-9, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24932537

RESUMO

BACKGROUND AND AIMS: Diverse waist circumference thresholds for assessment of metabolic and cardiovascular risk in Caucasians are recommended by different health professional organizations. We aimed to determine optimal sex-specific thresholds for anthropometric measures showing the strongest association with cardiovascular risk factors in a cohort of middle-aged Germans. METHODS AND RESULTS: Statistical analyses are based on data from 426 mothers and 267 fathers of participants of the Ulm Birth Cohort Study undergoing a clinical follow-up examination in 2008 (median age 41 years) using logistic regression analyses. The prevalence of many cardiometabolic risk factors was significantly higher in men than in women; hypertension: 45%/17% (p < 0.0001), apolipoprotein ratio B/A1 > 0.72: 35%/9% (<0.0001), hyperglycemia: 11%/14% (p = 0.3), which is in contrast to the predicted cardiovascular risk of 52%/70% and 24%/36% based on thresholds for waist circumference proposed by International Diabetes Federation and American Heart Association, respectively. We determined optimal thresholds for waist circumference between 90 and 95 cm for men and women. Using a threshold of 92 cm the prevalence of abdominal obesity was 59% in men and 24% in women, which was in agreement with the higher prevalence of overweight and obesity in men than in women (Body Mass Index (BMI) > 25: 64%/35%). The prediction of cardiometabolic risk factors by waist circumference and waist-to-height ratio did not outperform the prediction by BMI. In contrast to BMI, waist circumference was correlated with body height independent of sex. CONCLUSION: Currently proposed thresholds for waist circumference spuriously overestimate the cardiovascular risk in women, but not in men in a German population.


Assuntos
Doenças Cardiovasculares/epidemiologia , Obesidade Abdominal/epidemiologia , Circunferência da Cintura , Adulto , Apolipoproteína A-I/sangue , Apolipoproteínas B/sangue , Glicemia/metabolismo , Pressão Sanguínea , Composição Corporal , Índice de Massa Corporal , Doenças Cardiovasculares/prevenção & controle , Estudos de Coortes , Feminino , Seguimentos , Alemanha , Humanos , Insulina/sangue , Masculino , Pessoa de Meia-Idade , Obesidade Abdominal/prevenção & controle , Prevalência , Medição de Risco , Fatores de Risco , Razão Cintura-Estatura
2.
Thorac Cardiovasc Surg ; 59(1): 15-20, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21243566

RESUMO

Poststernotomy mediastinitis following median sternotomy procedures such as open heart surgery is a rare complication which nevertheless has a mortality rate of up to 50 %. Several treatment options are currently available; however, none of them are standardized. Based on the experience gained from open heart surgery performed at the MediClin Heart Institute Lahr/Baden, a therapeutic algorithm was developed. The treatment steps consist of repeated radical surgical debridement, sternal restabilization, vacuum-assisted closure therapy (VAC) as well as a surgical reconstruction via M. pectoralis plasty (MPP). This approach had a 30-day mortality of 0 % and a hospital mortality of 10.4 %. The approach proved to be safe and advantageous for specific patient groups operated on at the MediClin Heart Institute Lahr/Baden.


Assuntos
Infecções Bacterianas/complicações , Mediastinite/microbiologia , Esternotomia/efeitos adversos , Infecção da Ferida Cirúrgica/microbiologia , Idoso , Algoritmos , Antibacterianos/uso terapêutico , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/mortalidade , Infecções Bacterianas/terapia , Estudos de Casos e Controles , Desbridamento , Drenagem , Feminino , Humanos , Pacientes Internados , Masculino , Mediastinite/diagnóstico , Mediastinite/mortalidade , Mediastinite/cirurgia , Mediastinite/terapia , Tratamento de Ferimentos com Pressão Negativa/métodos , Músculos Peitorais/transplante , Procedimentos de Cirurgia Plástica/métodos , Padrões de Referência , Reoperação , Fatores de Risco , Infecção da Ferida Cirúrgica/complicações , Infecção da Ferida Cirúrgica/diagnóstico , Infecção da Ferida Cirúrgica/mortalidade , Infecção da Ferida Cirúrgica/terapia , Análise de Sobrevida , Resultado do Tratamento , Cicatrização
3.
Pediatr Obes ; 9(2): 121-34, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23420701

RESUMO

BACKGROUND: Although many epidemiological studies have shown an association between maternal smoking during pregnancy and offspring overweight, it is still under debate whether intrauterine tobacco smoke exposure directly affects offspring obesity or if the association is rather due to confounding by lifestyle factors. OBJECTIVES: The association of parental smoking habits at pre- and post-natal periods with offspring body mass index (BMI) was investigated, whereas maternal smoking during pregnancy was validated by cord serum cotinine measurements. METHODS: Multivariable linear regression analysis, based on the German Ulm Birth Cohort Study of 1045 children born in 2000 with annual/biennial follow-up until the age of 8 years (n = 609), was conducted. RESULTS: BMI of offspring from mothers who smoked during pregnancy and non-smoking mothers differed significantly at 8 years. Maternal smoking during pregnancy was associated with an increase in BMI of 0.73 kg m(-2) [95% confidence interval: 0.21-1.25] in 8-year-old children after adjustment for multiple potential confounding variables. Both pre- and post-natal smoking of fathers (0.34 [0.01-0.66]/0.45 [0.08-0.81]) and of both parents (1.03 [0.43-1.63]/0.56 [0.14-0.98]) were likewise significantly associated with offspring BMI. CONCLUSIONS: The observed patterns suggest that residual confounding by living conditions in smoking families rather than specific intrauterine exposure to tobacco smoke may account for the increased risk of offspring overweight.


Assuntos
Pai , Estilo de Vida , Mães , Obesidade Infantil/etiologia , Efeitos Tardios da Exposição Pré-Natal , Fumar , Poluição por Fumaça de Tabaco/efeitos adversos , Adulto , Composição Corporal , Índice de Massa Corporal , Criança , Pré-Escolar , Comportamento Alimentar , Feminino , Seguimentos , Alemanha/epidemiologia , Comportamentos Relacionados com a Saúde , Humanos , Lactente , Recém-Nascido , Masculino , Obesidade Infantil/epidemiologia , Obesidade Infantil/prevenção & controle , Gravidez , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Estudos Prospectivos , Fatores de Risco , Fumar/efeitos adversos , Fumar/epidemiologia , Fatores Socioeconômicos , Inquéritos e Questionários
4.
Thorac Cardiovasc Surg ; 56(8): 461-6, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19012210

RESUMO

BACKGROUND: When composite arterial T-grafts are used, uncertainty persists as to whether the RIMA will be long enough to reach the RCA. We present a formula for the preoperative estimation of the required conduit length. METHODS: The following formula was created to estimate the required conduit length for a sequential graft, starting from the proximal RIMA-LIMA T-graft anastomosis, passing the PLA, and ending at the PDA: 2.14 x ([2 x LV wall thickness [WT]) + end-diastolic diameter (EDD)]. The estimated length was compared to the measured length in 100 patients undergoing off-pump revascularisation with BIMA T-grafts. RESULTS: There were no hospital deaths, no major infarctions and no wound complications. The required conduit length varied from 11.5 cm to 19 cm (average 14.9 +/- 1.4 cm) and was excellently predicted by the formula (paired T-test: P < 0.001, r = 0.86, average overestimation: 0.55 cm). CONCLUSION: The formula reliably determines the minimum required conduit length. We recommend this formula for preoperative decision making when considering the choice of graft and the length of RIMA harvesting. To facilitate calculation a simplified version is useful: 2 x EDD + 4 x WD + 1. Avoiding uncertainty about the sufficiency of the RIMA length may contribute to the spread of this technique.


Assuntos
Anastomose de Artéria Torácica Interna-Coronária/métodos , Idoso , Ponte de Artéria Coronária sem Circulação Extracorpórea , Feminino , Humanos , Masculino , Artéria Torácica Interna/cirurgia
5.
Heart ; 91(8): 1023-9, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16020589

RESUMO

OBJECTIVE: To assess the benefit for patients older than 65 years of aortic valve replacement with stentless biological heart valves in comparison with mechanical valves. DESIGN: Multiple regression analysis of a retrospective follow up study. SETTING: Single cardiothoracic centre. PATIENTS: Between 1996 and 2001, 392 patients with a mean age of 74 years underwent aortic valve replacement with stentless Freestyle bioprostheses or mechanical St Jude Medical prostheses. MAIN OUTCOME MEASURE: Operative mortality and morbidity, postoperative morbid events, mid term survival, and New York Heart Association (NYHA) class improvement, and quality of life. RESULTS: No significant differences were found between patients receiving stentless biological valves and patients receiving mechanical prostheses. However, analysis of subgroups showed that patients older than 75 years with mechanical valves had an increased risk of major bleeding events (p = 0.007). Patients requiring anticoagulation by means of coumarin had a twofold increased risk of an impaired emotional reaction (p = 0.052). However, for patients who received a mechanical valve for severe combined aortic valve disease a survival advantage (p = 0.045) and a decreased risk of prolonged ventilation (p = 0.001) was observed. On the other hand, patients receiving a stentless bioprosthesis had an increased risk of a prolonged stay in intensive care (p = 0.04) and stroke (p = 0.01) if they had severely reduced cardiac function (NYHA class IV). CONCLUSIONS: Elderly people receiving stentless bioprostheses benefit emotionally because of the avoidance of coumarin. However, in patients with severe hypertrophied ventricles and extraordinary calcifications, stentless bioprostheses should be chosen with caution.


Assuntos
Valva Aórtica , Bioprótese , Doenças das Valvas Cardíacas/cirurgia , Próteses Valvulares Cardíacas , Complicações Pós-Operatórias/etiologia , Qualidade de Vida , Idoso , Endocardite/etiologia , Endocardite/mortalidade , Feminino , Seguimentos , Doenças das Valvas Cardíacas/mortalidade , Implante de Prótese de Valva Cardíaca/métodos , Implante de Prótese de Valva Cardíaca/mortalidade , Humanos , Masculino , Complicações Pós-Operatórias/mortalidade , Hemorragia Pós-Operatória/etiologia , Hemorragia Pós-Operatória/mortalidade , Reoperação , Estudos Retrospectivos , Acidente Vascular Cerebral/etiologia , Acidente Vascular Cerebral/mortalidade , Inquéritos e Questionários , Análise de Sobrevida , Resultado do Tratamento
6.
Z Kardiol ; 90 Suppl 6: 58-64, 2001.
Artigo em Alemão | MEDLINE | ID: mdl-11826823

RESUMO

Recently published studies suggest that the hemodynamic advantage of stentless bioprostheses in comparison to stented bioprostheses positively influence the long-term survival after aortic valve replacement. However, the more complex and time consuming implantation technique may increase the risk of operative death. Between April 1996 and September 2000, 201 patients with the mean age of 75 +/- 5 years underwent aortic valve replacement (AVR) with a stentless Medtronic Freestyle Bioprosthesis (FP) and 166 patients with a mean age of 77 +/- 5 years received a stented Medtronic Mosaic Bioprosthesis (MP). Patients requiring concomitant procedures other than coronary artery bypass grafting (CABG) were excluded. The operative mortality was 3.5% after AVR with the FP and 6% after AVR with the MP. Multiple logistic regression analysis considering the different patient populations revealed no increased risk of operative death after AVR with FB (p = 0.46). Previously heart operations (p = 0.046) and emergency operation (p = 0.022) were risk factors for operative death after AVR with the biological bioprostheses. The risk for postoperatively neurological impairment (p = 0.15) and other complications (p = 0.46) was furthermore not increased after implantation of a Freestyle stentless valve. The risk of delayed mobilization (p < 0.001) was 2.4-fold increased for patients after AVR with the Freestyle valve. A positive influence on survival due to the implantation of a stentless Freestyle valve could not be shown within the observed period. However, in spite of the more complex and time-consuming operation technique, the risk of operative death and postoperative complications is not increased after aortic valve replacement with the stentless FB.


Assuntos
Valva Aórtica , Bioprótese , Próteses Valvulares Cardíacas , Stents , Fatores Etários , Idoso , Animais , Seguimentos , Implante de Prótese de Valva Cardíaca/métodos , Humanos , Modelos Logísticos , Mortalidade , Razão de Chances , Complicações Pós-Operatórias , Fatores de Risco , Inquéritos e Questionários , Suínos , Fatores de Tempo
7.
Z Kardiol ; 90(Suppl 6): 58-64, 2001 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-24445789

RESUMO

Recently published studies suggest that the hemodynamic advantage of stentless bioprostheses in comparison to stented bioprostheses positively influence the long-term survival after aortic valve replacement. However, the more complex and time consuming implantation technique may increase the risk of operative death. Between April 1996 and September 2000, 201 patients with the mean age of 75 ± 5 years underwent aortic valve replacement (AVR) with a stentless Medtronic Freestyle Bioprothesis (FP) and 166 patients with a mean age of 77 ± 5 years received a stented Medtronic Mosaic Biopros thesis (MP). Patients requiring concomitant procedures other than coronary artery bypass grafting (CABG) were excluded. The operative mortality was 3.5% after AVR with the FP and 6% after AVR with the MP. Multiple logistic regression analysis considering the different patient populations revealed no increased risk of operative death after AVR with FB (p = 0.46). Previously heart operations (p = 0.046) and emergency operation (p = 0.022) were risk factors for operative death after AVR with the biological bioprostheses. The risk for postoperatively neurological impairment (p = 0.15) and other complications (p = 0.46) was furthermore not increased after implantation of a Freestyle stentless valve. The risk of delayed mobilization (p < 0.001) was 2.4-fold increased for patients after AVR with the Freestyle valve. A positive influence on survival due to the implantation of a stentless Freestyle valve could not be shown within the observed period. However, in spite of the more complex and time-consuming operation technique, the risk of operative death and postoperative complications is not increased after aortic valve replacement with the stentless FB.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA